CCMH
EBS icon

Cornerstone Capital Management Holdings’s Emergent Biosolutions EBS Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.03M Buy
22,180
+1,500
+7% +$63.1K 0.01% 898
2017
Q3 		$835K Buy
20,680
+2,200
+12% +$79.6K 0.01% 965
2017
Q2 		$626K Sell
18,480
-772
-4% -$23.8K ﹤0.01% 1002
2017
Q1 		$558K Sell
19,252
-59,675
-76% -$1.82M ﹤0.01% 1040
2016
Q4 		$2.59M Sell
78,927
-45,591
-37% -$1.37M 0.02% 667
2016
Q3 		$3.92M Buy
124,518
+71,052
+133% +$2.06M 0.03% 546
2016
Q2 		$1.5M Sell
53,466
-18,200
-25% -$714K 0.01% 803
2016
Q1 		$2.6M Buy
71,666
+13,739
+24% +$485K 0.02% 652
2015
Q4 		$2.32M Buy
57,927
+3,227
+6% +$113K 0.02% 694
2015
Q3 		$1.56M Buy
54,700
+37,000
+209% +$1.22M 0.01% 789
2015
Q2 		$583K Sell
17,700
-15,500
-47% -$481K 0.01% 963
2015
Q1 		$955K Sell
33,200
-25,000
-43% -$717K 0.01% 892
2014
Q4 		$1.58M Sell
58,200
-61,200
-51% -$1.46M 0.02% 779
2014
Q3 		$2.54M Buy
119,400
+47,200
+65% +$1.08M 0.03% 608
2014
Q2 		$1.62M Sell
72,200
-18,300
-20% -$426K 0.02% 764
2014
Q1 		$2.29M Sell
90,500
-70,577
-44% -$1.78M 0.03% 638
2013
Q4 		$3.7M Sell
161,077
-45,300
-22% -$944K 0.04% 468
2013
Q3 		$3.93M Sell
206,377
-47,500
-19% -$848K 0.05% 443
2013
Q2 		$3.66M Buy
+253,877
New +$3.68M 0.05% 461

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's EBS Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Emergent Biosolutions (EBS) stake by 7.3% in Q4 2017, buying an estimated $63.1K and bringing the position to 22,180 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #898.

Cornerstone Capital Management Holdings first reported a position in EBS in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.93M in Q3 2013. 238 funds tracked by Wall St. Rank hold EBS as of Q4 2017.

  • Cornerstone Capital Management Holdings held 22,180 shares of Emergent Biosolutions worth $1.03M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 1,500 Emergent Biosolutions shares in Q4 2017, an estimated $63.1K.
  • Emergent Biosolutions made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #898 holding.
  • Cornerstone Capital Management Holdings first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's Emergent Biosolutions position peaked at $3.93M in Q3 2013.
  • 238 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.